Style | Citing Format |
---|---|
MLA | Salarvand S, et al.. "The Quality of Guidelines in Non-Pharmacological Prevention and Management of Chemotherapy-Induced Neuropathy: A Review." Oncology Reviews, vol. 12, no. 2, 2018, pp. 129-133. |
APA | Salarvand S, Hemati S, Adibi P, Taleghani F (2018). The Quality of Guidelines in Non-Pharmacological Prevention and Management of Chemotherapy-Induced Neuropathy: A Review. Oncology Reviews, 12(2), 129-133. |
Chicago | Salarvand S, Hemati S, Adibi P, Taleghani F. "The Quality of Guidelines in Non-Pharmacological Prevention and Management of Chemotherapy-Induced Neuropathy: A Review." Oncology Reviews 12, no. 2 (2018): 129-133. |
Harvard | Salarvand S et al. (2018) 'The Quality of Guidelines in Non-Pharmacological Prevention and Management of Chemotherapy-Induced Neuropathy: A Review', Oncology Reviews, 12(2), pp. 129-133. |
Vancouver | Salarvand S, Hemati S, Adibi P, Taleghani F. The Quality of Guidelines in Non-Pharmacological Prevention and Management of Chemotherapy-Induced Neuropathy: A Review. Oncology Reviews. 2018;12(2):129-133. |
BibTex | @article{ author = {Salarvand S and Hemati S and Adibi P and Taleghani F}, title = {The Quality of Guidelines in Non-Pharmacological Prevention and Management of Chemotherapy-Induced Neuropathy: A Review}, journal = {Oncology Reviews}, volume = {12}, number = {2}, pages = {129-133}, year = {2018} } |
RIS | TY - JOUR AU - Salarvand S AU - Hemati S AU - Adibi P AU - Taleghani F TI - The Quality of Guidelines in Non-Pharmacological Prevention and Management of Chemotherapy-Induced Neuropathy: A Review JO - Oncology Reviews VL - 12 IS - 2 SP - 129 EP - 133 PY - 2018 ER - |